Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilhelm

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Resuscitation|November 24, 2001
Plasma epinephrine levels after epinephrine administration using different tracheal administration techniques in an adult CPR porcine modelL L Mielke, M J Lanzinger, C Aschke, et al.
Disease Markers|November 16, 2017
The Predictive Value of <i>PITX2</i> DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and ChallengesMichaela Aubele, Manfred Schmitt, Rudolf Napieralski, et al.
Journal of Cellular Physiology|July 8, 1999
Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expressionO G Wilhelm, S Wilhelm, G M Escott, et al.
Biological Chemistry|October 11, 2001
Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)V Magdolen, M Bürgle, N A de Prada, et al.
Breast Care (Basel, Switzerland)|November 1, 2021
PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer PatientsRudolf Napieralski, Gabriele Schricker, Gert Auer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 18, 2006
Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinomaK Ridwelski, J Fahlke, R Kuhn, et al.
Thrombosis Research|March 9, 2000
Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptidesB Muehlenweg, E Guthaus, N A de Prada, et al.
Science (New York, N.Y.)|May 31, 2014
Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteinsBenjamin G Wilhelm, Sunit Mandad, Sven Truckenbrodt, et al.
Endocrinology|September 24, 2005
PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growthAmy Y M Au, Claire McBride, Kenneth G Wilhelm, et al.
Breast Care (Basel, Switzerland)|February 26, 2019
Clinical Validation of <i>PITX2</i> DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based ChemotherapyManfred Schmitt, Olaf G Wilhelm, Aurelia Noske, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Resuscitation|November 24, 2001
Plasma epinephrine levels after epinephrine administration using different tracheal administration techniques in an adult CPR porcine modelL L Mielke, M J Lanzinger, C Aschke, et al.
Disease Markers|November 16, 2017
The Predictive Value of <i>PITX2</i> DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and ChallengesMichaela Aubele, Manfred Schmitt, Rudolf Napieralski, et al.
Journal of Cellular Physiology|July 8, 1999
Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expressionO G Wilhelm, S Wilhelm, G M Escott, et al.
Biological Chemistry|October 11, 2001
Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)V Magdolen, M Bürgle, N A de Prada, et al.
Breast Care (Basel, Switzerland)|November 1, 2021
PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer PatientsRudolf Napieralski, Gabriele Schricker, Gert Auer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 18, 2006
Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinomaK Ridwelski, J Fahlke, R Kuhn, et al.
Thrombosis Research|March 9, 2000
Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptidesB Muehlenweg, E Guthaus, N A de Prada, et al.
Science (New York, N.Y.)|May 31, 2014
Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteinsBenjamin G Wilhelm, Sunit Mandad, Sven Truckenbrodt, et al.
Endocrinology|September 24, 2005
PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growthAmy Y M Au, Claire McBride, Kenneth G Wilhelm, et al.
Breast Care (Basel, Switzerland)|February 26, 2019
Clinical Validation of <i>PITX2</i> DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based ChemotherapyManfred Schmitt, Olaf G Wilhelm, Aurelia Noske, et al.
Pageof 5